Polyphyletic Origin of Vibrio vulnificus Biotype 2 as Revealed by Sequence-Based Analysis by Sanjuán Caro, Eva et al.
  Published Ahead of Print 19 November 2010. 
10.1128/AEM.01263-10. 
2011, 77(2):688. DOI:Appl. Environ. Microbiol. 
Amaro
Eva Sanjuán, Fernando González-Candelas and Carmen
 
Analysis 
Biotype 2 as Revealed by Sequence-Based 
Vibrio vulnificusPolyphyletic Origin of 
http://aem.asm.org/content/77/2/688
Updated information and services can be found at: 
These include:
SUPPLEMENTAL MATERIAL
 
l
http://aem.asm.org/content/suppl/2010/12/29/77.2.688.DC1.htm
REFERENCES
http://aem.asm.org/content/77/2/688#ref-list-1at: 
This article cites 26 articles, 18 of which can be accessed free
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://aem.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 M
arch 13, 2012 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Jan. 2011, p. 688–695 Vol. 77, No. 2
0099-2240/11/$12.00 doi:10.1128/AEM.01263-10
Copyright © 2011, American Society for Microbiology. All Rights Reserved.
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A sequence-based analysis of seven housekeeping and virulence-related genes shows that the species Vibrio
vulnificus is subdivided into three phylogenetic lineages that do not correspond with the biotypes and that
biotype 2 is polyphyletic. These results support the reclassification of biotype 2 as a pathovar that would group
the strains with pathogenic potential to develop vibriosis in fish.
Vibrio vulnificus is a pathogenic bacterial species that inhab-
its brackish waters in warm and tropical ecosystems (9, 11, 24).
The species is highly heterogeneous and has been subdivided
into three biotypes. Biotype 1 is the most abundant; it is dis-
tributed worldwide and causes sporadic cases of human vibri-
osis. Biotype 2 is also distributed worldwide, and it is the only
one that harbors the genetic information to infect both fish and
humans. Finally, biotype 3 is geographically restricted to Israel,
and it causes outbreaks of human vibriosis after fish handling
(1, 4, 13, 25). Biotype 2 is further subdivided into serovars A,
E, and I (7; unpublished results), serovar E being the one
associated with human vibriosis (1).
The genes essential for fish vibriosis are located in a recently
described virulence plasmid that can be transmitted between
strains cointegrated with a conjugative plasmid (12) that is
present in almost 90% of biotype 2 isolates (17). In contrast,
the genetic basis of human infection is poorly understood,
since the putative virulence factors identified so far are found
in both clinical and environmental isolates of the three bio-
types (24, 27).
Several studies based on multilocus sequence typing (MLST)
of housekeeping genes (2, 3, 6) and on ribotyping (21) suggest
that the species is subdivided into two main evolutionary
lineages with apparently different human pathogenic poten-
tial; one includes a majority of the human clinical isolates of
biotype 1 (clinical branch), and the other a majority of the
environmental isolates of the same biotype (environmental
branch). The few isolates of biotype 2 studied are in the
environmental branch, while biotype 3 strains are in a vari-
able position depending on the study (2, 3, 6).
Given this scenario, the aim of this work has been to analyze
the evolutionary origins of biotype 2, starting from the hypoth-
esis that horizontal transfer of the virulence plasmid together
with recombination events could have played a major role in
the emergence of this biotype. To this end, a sequence-based
analysis of three virulence-associated (vvhA, wzz, and pilF)
and four housekeeping (glp, mdh, pyrC, and pntA) genes (the
last ones selected from the MLST scheme for V. vulnificus
[3]) was applied to a collection of 115 isolates that included
strains of the three biotypes from clinical (humans and fish)
and environmental sources (Table 1). The primer pairs for
the genes are listed in Table S1 in the supplemental mate-
rial. The genetic variability () at the locus and biotype level
was examined by using DnaSP4.09 (20). pilF and wzz (genes
involved in surface antigen biogenesis) showed the highest
levels of genetic variability (Table 2). Regarding the bio-
types, biotype 1 showed the highest genetic variability, while
biotype 2 was highly homogeneous, and no genetic diversity
was observed among the biotype 3 isolates (see Table S2 in
the supplemental material).
To analyze the phylogeny of the V. vulnificus collection, we
constructed a maximum likelihood (ML) tree from the 3,159-bp
concatenated sequence of the seven loci (Fig. 1) by using
PHYML 2.4.4 (8). The most appropriate model for nucleotide
substitution was assessed with Modeltest version 3.7 (16). The
concatenated tree shows the isolates clustered into three main
lineages (Fig. 1). Lineage I (LI) contained isolates of biotypes
1 and 2 from fish farms and isolates from diseased fish and
humans infected through fish handling or water contact. This
lineage is enriched in European isolates, probably because the
fish-farming industry is especially developed in Europe, whose
countries apply specific-pathogen-control programs. LII was
formed by biotype 3 strains from Israel, and LIII included bio-
type 1 isolates mostly recovered from environmental sam-
ples or from human septicemic cases registered in the United
States and Asia. The nucleotide diversity within each lineage
was then examined, and it was found that LI and LIII have
similar values ( in Table S2 in the supplemental material).
The human isolates are genetically more diverse than those
from environmental origins, and both are much more diverse
than isolates from diseased animals. This result would suggest
that multiple environmental clones have the ability to infect
humans, which correlates with human cases being presented as
sporadic infections worldwide, and that only a few clones are
able to infect fish, although they are overrepresented by clone
* Corresponding author. Mailing address: Departamento de Micro-
biología, Facultad de Biología, Universidad de Valencia, 46100 Valen-
cia, Spain. Phone: 34 96 354 31 04. Fax: 34 96 354 45 70. E-mail:
carmen.amaro@uv.es.
† Supplemental material for this article may be found at http://aem
.asm.org/.
 Published ahead of print on 19 November 2010.
688
 o
n
 M
arch 13, 2012 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
TABLE 1. Characteristics of the V. vulnificus isolates used in this study
Strain Country and yrof isolation Source Biotype
a and serovar STb
No. of allelic sequencesb of:
glp pntA pyrC pilF wzz vvhA mdh
YJ106 Taiwan Human blood BT1/3 1 1 1 30 18 1 21 5
CECT 4608 Spain, 1990 Eel farm water BT1/3 2 1 2 12 11 11 2 13
BT3-1033 Israel, 1996 Diseased human BT1/3 3 2 5 2 10 13 5 10
BT3-11028 Israel, 1996 Diseased human BT1/3 3 2 5 2 10 13 5 10
BT3-12 Israel, 1996 Diseased human BT1/3 3 2 5 2 10 13 5 10
BT3-162 Israel, 1997 Diseased human BT1/3 3 2 5 2 10 13 5 10
BT3-32 Israel Diseased human BT1/3 3 2 5 2 10 13 5 10
BT3-97 Israel, 1997 Diseased human BT1/3 3 2 5 2 10 13 5 10
A13 Spain, 2002 Diseased eel BT2 non-serovar E
(serovar A)
4 3 7 3 1 2 7 6
CECT 5198 Spain, 1999 Diseased eel BT2 non-serovar E
(serovar A)
5 3 7 3 1 2 7 8
CECT 7029 Denmark, 2004 Diseased eel BT2 non-serovar E
(serovar A)
5 3 7 3 1 2 7 8
CECT 7030 Denmark, 2004 Diseased eel BT2 non-serovar E
(serovar A)
5 3 7 3 1 2 7 8
A10 Spain, 2002 Diseased eel BT2 non-serovar E
(serovar A)
5 3 7 3 1 2 7 8
CECT 5343 Spain, 2000 Diseased eel BT2 non-serovar E
(serovar A)
6 3 7 3 1 2 7 28
A11 Spain, 2002 Diseased eel BT2 non-serovar E
(serovar A)
7 3 7 3 1 2 7 32
CECT 5689 Spain, 2002 Diseased eel BT2 non-serovar E
(serovar A)
8 3 7 17 1 2 7 29
CECT 5768 Spain, 2001 Diseased eel BT2 non-serovar E
(serovar A)
9 3 7 17 1 2 7 30
CECT 5769 Spain, 2002 Diseased eel BT2 non-serovar E
(serovar A)
10 3 7 17 1 2 7 31
L49 Japan Brackish water BT1/3 11 3 7 26 1 2 7 6
PD-2-66 Spain, 2003 Eel tank water BT1/3 12 3 8 26 25 28 15 8
JE USA Oyster BT1/3 13 3 15 13 2 24 1 25
CECT 5166 USA Human blood BT1/3 14 3 18 15 14 16 2 14
CECT 4867 Unknown Diseased eel BT1/3 15 4 22 31 26 3 15 33
534 Sweden Diseased eel BT1/3 16 5 8 4 2 4 12 8
CECT 4869 Belgium, 1990 Diseased eel BT1/3 17 5 8 13 2 14 19 1
A2 Spain, 2000 Eel tank water BT1/3 18 6 11 4 2 11 2 7
An4 Spain, 2000 Eel tank water BT1/3 18 6 11 4 2 11 2 7
An5 Spain, 2000 Eel tank water BT1/3 18 6 11 4 2 11 2 7
An6 Spain, 2000 Eel tank water BT1/3 18 6 11 4 2 11 2 7
An7 Spain, 2000 Eel tank water BT1/3 18 6 11 4 2 11 2 7
PD-1 Spain, 2001 Eel tank water BT1/3 18 6 11 4 2 11 2 7
PD-3 Spain, 2001 Eel tank water BT1/3 18 6 11 4 2 11 2 7
PD-5 Spain, 2001 Eel tank water BT1/3 18 6 11 4 2 11 2 7
V1 Spain, 2001 Eel tank water BT1/3 18 6 11 4 2 11 2 7
PD-12 Spain, 2001 Eel tank water BT1/3 19 6 11 4 23 11 2 7
CECT 4606 Spain, 1990 Healthy eel BT1/3 20 6 11 4 4 3 2 8
MLT 362 USA Environmental BT1/3 21 7 4 21 8 25 16 33
VV 1003 USA Environmental BT1/3 22 8 23 28 27 29 14 24
MLT 364 USA Environmental BT1/3 23 9 24 24 8 9 16 8
MLT 406 USA Environmental BT1/3 24 10 19 26 2 3 2 1
MLT404 USA Environmental BT1/3 25 11 20 25 21 26 7 33
ATCC 33816 USA Human blood BT1/3 26 12 9 12 16 12 7 4
CG100 Taiwan, 1993 Oyster BT1/3 27 12 9 12 15 20 9 2
V2 Unkown Environmental BT1/3 28 12 9 12 16 12 13 4
CG110 Taiwan, 1993 Seawater BT1/3 29 12 9 19 15 12 4 D3
VV 352 USA Environmental BT1/3 30 12 9 29 16 12 17 19
CG111 Taiwan, 1993 Seawater BT1/3 31 12 14 20 15 12 4 2
CG118 Taiwan, 1993 Seawater BT1/3 32 12 14 20 15 12 4 4
CG106 Taiwan, 1993 Oyster BT1/3 33 12 14 21 17 21 18 3
CECT 5167 Japan Human blood BT1/3 34 13 14 16 15 17 4 12
VV 425 USA Environmental BT1/3 35 13 21 4 18 31 5 27
CECT 5164 USA Human blood BT1/3 36 14 3 12 13 15 20 20
CECT 5169 USA Human blood BT1/3 37 15 7 4 17 19 11 22
CS9133 South Korea Human blood BT1/3 38 15 14 22 18 22 10 22
KH03 Japan, 2003 Human blood BT1/3 39 16 14 12 19 18 4 23
Continued on following page
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TABLE 1—Continued
Strain Country and yrof isolation Source Biotype
a and serovar STb
No. of allelic sequencesb of:
glp pntA pyrC pilF wzz vvhA mdh
E4 USA Seafood BT1/3 40 16 14 21 19 18 4 26
V4 Australia Human blood BT1/3 41 17 14 27 18 30 22 23
94-9-118 Denmark, 1994 Expectoration from lungs BT1/3 42 18 22 5 2 5 1 8
G83 South Korea Fish BT1/3 43 19 16 23 20 23 8 8
CECT 5168 USA Human blood BT1/3 44 20 7 4 16 18 4 21
YN03 Japan, 2003 Human blood BT1/3 45 21 13 9 12 32 7 7
94385 Spain, 2001 Leg wound BT1/3 46 22 14 8 6 8 8 7
536 Sweden Diseased eel BT2 non-serovar E 47 23 10 3 3 2 7 8
535 Sweden Diseased eel BT2 non-serovar E 48 23 10 3 3 2 7 15
CECT 5165 USA Seawater BT1/3 49 23 21 14 14 3 2 8
Riu-1 Spain, 2003 Seawater BT1/3 50 24 16 8 20 7 8 7
94-9-130 Denmark, 1994 Water BT1/3 51 25 8 7 5 7 1 8
Riu-3 Spain, 2003 Seawater BT1/3 52 25 12 3 24 12 1 8
PD-2-58 Spain, 2003 Eel tank water BT2 non-serovar E 53 25 12 3 24 3 1 8
PD-2-52 Spain, 2003 Eel tank water BT2 non-serovar E 54 25 12 3 24 27 1 8
94-9-119 Denmark, 1994 Wound infection BT1/3 55 26 17 6 2 6 1 8
A14 Spain, 2002 Diseased eel BT2 non-serovar E 56 27 7 3 1 2 7 8
95-8-161 Denmark, 1995 Diseased eel BT2 non-serovar E
(serovar I)
57 28 7 9 7 2 7 16
95-8-162 Denmark, 1995 Diseased eel BT2 non-serovar E
(serovar I)
58 28 7 9 7 2 7 17
95-8-6 Denmark, 1995 Diseased eel BT2 non-serovar E
(serovar I)
59 28 7 10 7 2 7 8
95-8-7 Denmark, 1995 Diseased eel BT2 non-serovar E
(serovar I)
60 28 7 11 8 2 7 8
CIP 81.90 France Human blood BT2 serovar E 61 29 7 4 4 3 3 8
CECT 4862 Japan, 1979 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
90-2-11 Denmark, 1990 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
94-8-112 Denmark, 1994 Wound infection BT2 serovar E 62 29 8 4 4 3 3 8
94-9-123 Denmark, 1994 Seawater BT2 serovar E 62 29 8 4 4 3 3 8
CCUG 38521 Sweden, 1997 Wound infection BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4174 Japan, 1979 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4601 Spain, 1989 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4602 Spain, 1990 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4603 Spain, 1990 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4605 Spain, 1990 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4607 Spain, 1992 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4863 USA Leg wound infection BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4864 Spain, 1994 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4865 Taiwan Diseased shrimp BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4866 Australia Human blood BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4870 Sweden, 1991 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4917 Spain, 1997 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
CECT 897 Japan, 1979 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
CECT 898 Japan, 1979 Diseased eel BT2 serovar E 62 29 8 4 4 3 3 8
PD-2-47 Spain, 2003 Eel tank water BT2 serovar E 62 29 8 4 4 3 3 8
PD-2-55 Spain, 2003 Eel tank water BT2 serovar E 62 29 8 4 4 3 3 8
PD-2-56 Spain, 2003 Eel tank water BT2 serovar E 62 29 8 4 4 3 3 8
Riu-2 Spain, 2003 Seawater BT2 serovar E 62 29 8 4 4 3 3 8
UE516 Taiwan Diseased Japanese eel BT2 serovar E 62 29 8 4 4 3 3 8
CECT 4868 Norway, 1990 Diseased eel BT2 serovar E 63 29 8 4 4 3 3 10
CECT 4999 Spain, 1999 Diseased eel BT2 serovar E 64 29 8 4 4 3 3 16
C1 Spain, 2003 Healthy eel BT2 serovar E 65 29 8 4 4 3 3 17
CECT 4604 Spain, 1990 Diseased eel BT2 serovar E 66 29 8 4 4 3 3 18
CECT 4998 Spain, 1997 Diseased eel BT2 serovar E 66 29 8 4 4 3 3 18
CECT 5139 Spain, 1998 Diseased eel BT2 serovar E 66 29 8 4 4 3 3 18
PD-2-50 Spain, 2003 Eel tank water BT2 serovar E 67 29 8 4 4 3 3 32
PD-2-51 Spain, 2003 Eel tank water BT2 serovar E 67 29 8 4 4 3 3 32
CECT 5762 Spain, 2002 Healthy eel BT2 serovar E 68 29 8 18 4 3 3 17
CECT 5763 Spain, 2002 Eel tank water BT2 serovar E 69 29 8 18 4 3 3 8
CECT 529T USA Human blood BT1/3 70 29 18 15 14 16 2 14
960717-1/2F Denmark, 1996 Diseased eel BT2 non-serovar E 71 30 6 4 9 6 1 11
960426-1/4C Denmark, 1996 Diseased eel BT2 non-serovar E 72 30 6 4 9 10 6 11
N87 Japan, 1987 Human blood BT1/3 73 31 4 1 22 33 4 9
a BT, biotype.
b Sequences from each locus were aligned using Vector NTI 9.0.0 software (Infomax) and were edited manually by visual inspection. Different allelic sequences within
a locus were assigned arbitrary numbers. Each isolate was consequently given a 7-number sequence designated a sequence type (ST).
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FIG. 1. Maximum likelihood phylogenetic tree of 115 V. vulnifi-
cus isolates obtained from the alignment of 7 concatenated loci.
Black, biotype 1 isolates; blue, biotype 2 serovar E isolates; red,
biotype 2 non-serovar E isolates; green, biotype 3 isolates; #, hu-
man isolates; §, diseased fish isolates. Branches where recombina-
tion events involving the indicated loci might have occurred are
indicated by arrows. The numbers at the nodes represent the per-
centage values given by bootstrap analysis of 1,000 replicates.
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amplification after epizootics in fish farms. The exception
would be the clone formed by biotype 3 isolates, the only ones
capable of causing outbreaks of human vibriosis.
Furthermore, LI can be subdivided into four main groups,
as follows: LI-A, grouping all biotype 2 serovar E isolates
plus a Spanish biotype 1 isolated from a fish tank (CECT
4606); LI-B, formed by two atypical isolates of biotype 2
from Denmark; LI-C, clustering all non-serovar E biotype 2
isolates together with biotype 1 isolates from fish farms and
humans; and lastly, LI-D, grouping biotype 1 isolates from
the environment and humans (mainly from blood). Thus,
biotype 2 is polyphyletic and appears to be divided into
serovar-related subgroups, the isolates in each subgroup
being more related to biotype 1 isolates from fish farms than
to each other. This result is compatible with the hypothesis
that biotype 2 emerged by acquisition of the virulence plas-
mid by V. vulnificus strains from fish farms.
The groupings of strains changed when only virulence or
housekeeping genes were considered (Fig. 2). In both cases,
the position of biotype 3 changed, and this also occurred in the
individual gene trees (Fig. S1 to S5 in the supplemental mate-
rial). Previous studies of the phylogeny of V. vulnificus (based
on different techniques, multilocus enzyme electrophoresis,
MLST, or 16S rRNA or gene sequencing) divided the species
into two main lineages, the clinical and the environmental
lineages (5, 6, 10, 15, 19, 23, 26). In our study, the division in
the two lineages was observed in the phylogenetic trees from
virulence-related or from housekeeping genes but not in the
concatenated phylogenetic tree. Thus, it can be concluded
that combining four housekeeping and three virulence gene
sequences in the analysis gives enough resolution to show
biotype 3 as an independent lineage. Bisharat et al. (3)
proposed that biotype 3 contains a mosaic genome that
would have evolved by hybridization of genomes of repre-
sentative strains of the other two lineages. Our results sup
FIG. 2. Maximum likelihood phylogenetic tree of 115 V. vulnificus
isolates obtained from the alignment of 4 housekeeping (A) and 3
virulence-associated (B) concatenated loci. Symbols indicate isolates
that cluster in LI-A (F), LI-B (f), LI-C (Œ), LI-D (}), LII (E), or LIII
() in the concatenated tree. The numbers at the nodes represent the
percentage values given by bootstrap analysis of 1,000 replicates.
TABLE 3. Likelihood scores for the loci identified as involved in
recombination eventsa
Alignment
lnL for ML tree of the:
Locus Concatenated loci
pilF 3,136.12 4,148.14/
Concatenated loci without pilF 11,095.79/ 9,753.16
wzz 3,125.20 4,001.95/
Concatenated loci without wzz 11,302.35/ 9,503.07
a For each recombinant locus, we considered two multiple alignments, the one
from that locus and that obtained from the concatenated alignment of the other
6 loci. These two alignments were used to evaluate the likelihood (lnL, nega-
tive natural log of the likelihood) of the ML trees obtained with each of them,
and the tree obtained with each alignment is compared with that derived from
the other by the Shimodaira-Hasegawa (SH) and expected likelihood weight
(ELW) tests. Levels of significance for the SH/ELW tests: , P  0.001.
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FIG. 3. Maximum likelihood phylogenetic trees from 6 of the 7 concatenated loci, excluding region pilF (A) and the pilF locus (B). Isolates
identified as recombinants are marked with a filled circle, while the putative parental isolates are marked with an open circle. The numbers at the
nodes represent the percentage values given by bootstrap analysis of 1,000 replicates.
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FIG. 4. Maximum likelihood (ML) phylogenetic trees from 6 of the 7 concatenated loci, excluding region wzz (A) and the wzz locus (B). Isolates
identified as recombinants are marked with a filled circle, while the putative parental isolates are marked with an open circle. The numbers at the
nodes represent the percentage values given by bootstrap analysis of 1,000 replicates.
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port this hypothesis, although the change of position in the
trees affected not only biotype 3 isolates but also biotype 2
non-serovar E isolates and biotype 1 strains, mostly from
fish-farming environments (Fig. 2; also see Fig. S1 to S5 in
the supplemental material).
The Recombination Detection Program, version 3 (RDP3)
(14) detected recombination in chromosome I by at least four
of the implemented methods, involving two of the four loci
(pilF and wzz). The putative recombinant events were mapped
onto the phylogenetic tree of the seven concatenated loci (Fig.
1). To further corroborate the RDP3 results, two different ML
trees were constructed for each recombinant locus. The tree
obtained from the multiple sequence alignment of each locus
was compared with the one obtained from the concatenated
sequences of all the other loci by using TreePuzzle version 5.2
(22). In both cases, Shimodaira-Hasegawa (SH) and expected
likelihood weight (ELW) tests revealed significant differences
between the two topologies (Table 3). Figures 3 and 4 each
show the phylogenetic tree of one of the loci involved in recom-
bination (pilF and wzz) and the tree derived from the remaining
aligned loci. In both cases, biotype 2 serovar E strains are involved
in the recombination events, either as predicted parental strains,
in wzz, or as daughter strains, in pilF. The other strains involved in
recombination events are biotype 2 nontypeable strains and clin-
ical and environmental biotype 1 isolates. This result suggests that
the conditions of aquaculture settings (e.g., high nutrient loads
and high host density) might favor the exchange of genetic ma-
terial among strains of V. vulnificus, originating new variants in
the V. vulnificus species.
Interestingly, the pilF ML tree splits the strains into two
groups, one that clusters most clinical biotype 1 isolates from
humans together with biotype 3 and biotype 2 serovar E iso-
lates from human origins and another that groups serovar A
and I isolates together with environmental biotype 1 isolates
(Fig. 3B), suggesting that pilF could be used as a genetic
marker to distinguish isolates potentially dangerous to hu-
mans. A PCR-based protocol to distinguish V. vulnificus iso-
lates with pathogenic potential against humans based on the
polymorphism in pilF has been designed and validated in our
laboratory (18).
Conclusion. The V. vulnificus species is subdivided into three
different phylogenetic lineages which do not correspond to the
current intraspecific biotype classification. LI and LII seem to
have evolved in fish-farming-related environments where
recombination or/and horizontal transfer phenomena would
have favored the emergence of pathogenic clones for fish or
humans, which would have been amplified after outbreaks
of fish (biotype 2) or human (biotype 3) vibriosis. The
polyphyletic origin of the so-called biotype 2 supports its
reclassification within the species as a pathovar that would
group the strains with pathogenic potential to infect and
develop vibriosis in fish.
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